Regal Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Regal Investment Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-26,688	Closed	-$3.37M	–	375
2018 Q3	$3.37M	Buy	26,688 +2,514	+10%	+$266K	0.71%	35
2018 Q2	$2.03M	Sell	24,174 -5,337	-18%	-$391K	0.62%	43
2018 Q1	$1.82M	Sell	29,511 -636	-2%	-$38.3K	0.4%	82
2017 Q4	$1.76M	Buy	+30,147	New	+$1.9M	0.39%	90
2015 Q4	–	Sell	-50	Closed	-$8K	–	923
2015 Q3	$8K	Buy	+50	New	+$11K	﹤0.01%	747

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Regal Investment Advisors's ICPT Position: Q4 2018 in Review

Regal Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2018, closing a stake of 26,688 shares — an estimated $3.37M sold.

Regal Investment Advisors first reported a position in ICPT in Q3 2015 and held it in 5 quarters. The position peaked at $3.37M in Q3 2018. 191 funds tracked by Wall St. Rank hold ICPT as of Q4 2018.

Regal Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Regal Investment Advisors sold 26,688 Intercept Pharmaceuticals, Inc. shares in Q4 2018, an estimated $3.37M.
Regal Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Regal Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $3.37M in Q3 2018.
191 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2018.

Based on Regal Investment Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.